Home » Posts tagged with » Canada
Amplia Pharmatek acquired by NuChem Therapeutics

Amplia Pharmatek acquired by NuChem Therapeutics

NuChem Therapeutics has wrapped up the acquisition of Amplia Pharmatek, a Quebec-based drug discovery and development contract research organization (CRO) with a focus on biology. Based in Montreal, NuChem Therapeutics too is a drug discovery and development CRO. The company specializes in synthetic and medicinal chemistry services. Amplia Pharmatek, on the other hand, is a […]

Mindmed acquires 18-MC opioid addiction drug candidate from Savant HWP

Mindmed acquisition of 18-MC : Canada-based Mind Medicine (Mindmed) has acquired opioid addiction drug candidate 18-MC from Savant HWP for an undisclosed price, as per the latest pharma acquisition news. 18-MC, which is derived from ibogaine – a natural psychedelic substance, is being developed for addressing the opioid crisis and other types of addiction. The […]

Continue reading …
Cutera truSculpt iD body sculpting treatment gets expanded approval in Canada

Cutera said that Health Canada has expanded approval for its truSculpt iD body sculpting treatment to cover its use for the reduction of circumference of the abdomen and non-invasive lipolysis, which is the permanent removal of fat cells from the body. According to American Society for Aesthetic Plastic Surgery and Medical Insight (MII), noninvasive body sculpting […]

Continue reading …
Mallinckrodt to sell Canadian CDMO BioVectra to H.I.G. Capital for $250m

Mallinckrodt sale of BioVectra to H.I.G. Capital : Irish biopharma company Mallinckrodt has agreed to divest its wholly-owned subsidiary BioVectra, a Canadian CDMO (contract development and manufacturing organization) to an affiliate of H.I.G. Capital for nearly US$250 million, as per the latest pharma acquisition news. The transaction amount to be paid by H.I.G. Capital, which is […]

Continue reading …
Khiron begins construction on medical cannabis production plant in Uruguay

Khiron Life Sciences, a Canadian cannabis producer, has begun the construction on a new medical cannabis production plant in Uruguay, thereby expanding multi-jurisdiction and export capacity. The new cannabis cultivation and processing facility is located in Juan Lacaze. The medical cannabis production plant with a production capacity of 17 tons per year will increase Khiron […]

Continue reading …
Neoleukin completes merger with Aquinox Pharmaceuticals

US biopharma company Neoleukin Therapeutics has wrapped up a previously announced merger with Canadian pharma company Aquinox Pharmaceuticals. Headquartered in Vancouver, Aquinox Pharmaceuticals focused on discovering and developing novel therapeutics for conditions related to inflammation, inflammatory pain, and blood cancers. On the other hand, Neoleukin creates next-generation immunotherapies by using its de novo protein design […]

Continue reading …
US CDMO Avara acquires sterile manufacturing facility in Boucherville from Sandoz

Avara Pharmaceutical Services, a US CDMO (contract development and manufacturing organization), has completed a previously announced acquisition of a Canadian sterile manufacturing facility for injectable medicines in Boucherville, Quebec, from Novartis’ Sandoz division. The financial terms of the acquisition of the injectables production facility were not disclosed. The deal, which marks the entry of the […]

Continue reading …